The Existential Threat How Tariffsanda Science Pushare Challenging Curefits Visionfor Indias Future

Published in Science and Technology on Wednesday, August 20th 2025 at 13:25 GMT by Business Today
^{🞛 This publication is a summary or evaluation of another publication 🞛 This publication contains editorial commentary or bias from the source}

Mukesh Bansal, co-founder of fitness and wellness giant Curefit, recently voiced a stark warning about the future of Indian innovation – an existential threat stemming from escalating import tariffs coupled with a government push towards “science” that isn’t always aligned with practical needs. His concerns, articulated in a LinkedIn post and subsequently picked up by Business Today, highlight a growing disconnect between policy intentions and their real-world consequences for businesses striving to build advanced, technology-driven solutions within India.

Bansal's primary grievance centers on the increasingly prohibitive cost of importing essential components required for Curefit’s operations, particularly its fitness equipment and diagnostic tools. With tariffs now reaching 50% on many imported goods, the financial burden is becoming unsustainable, forcing difficult decisions about product development and expansion plans. This isn't just a Curefit problem; it represents a broader challenge facing numerous Indian companies reliant on global supply chains for specialized components and technology.

The core of Bansal’s argument lies in the paradoxical situation created by the government’s stated ambition to foster innovation and self-reliance ("Atmanirbhar Bharat") while simultaneously erecting trade barriers that stifle access to crucial resources. While promoting domestic manufacturing is a laudable goal, imposing high tariffs without first establishing robust local alternatives creates an artificial scarcity and significantly increases costs for businesses operating within India. This ultimately hinders their ability to compete globally and innovate effectively.

He specifically points to the challenges faced in procuring advanced diagnostic equipment used in Curefit’s healthcare offerings. These devices often incorporate sophisticated sensors and components that are not yet manufactured locally, making imports a necessity. The 50% tariff dramatically increases the cost of these tools, impacting affordability for consumers and limiting Curefit's ability to expand its reach into underserved areas.

Beyond the direct financial impact, Bansal argues that high tariffs create a chilling effect on innovation. Companies become hesitant to invest in new product development or explore cutting-edge technologies when faced with unpredictable costs and supply chain disruptions. The uncertainty discourages risk-taking and ultimately slows down the pace of technological advancement within India.

Adding another layer of complexity is what Bansal terms the government’s “science push” – a focus on promoting research and development in specific scientific areas, often without sufficient consideration for market demand or practical application. While investment in science is undoubtedly crucial, he argues that it needs to be aligned with the needs of businesses and consumers. Simply funding research projects doesn't guarantee that those discoveries will translate into viable products or services that can benefit society.

Bansal’s critique isn’t a rejection of scientific advancement; rather, it’s a plea for a more pragmatic approach – a “market pull” – where innovation is driven by real-world needs and supported by policies that facilitate access to the necessary resources. He emphasizes the importance of fostering an ecosystem that encourages collaboration between researchers, entrepreneurs, and policymakers to ensure that scientific breakthroughs are translated into tangible benefits for all.

The situation highlights a critical tension within India’s economic development strategy. While protectionist measures might seem appealing in the short term, they can ultimately stifle innovation, increase costs for consumers, and hinder long-term competitiveness. The Curefit founder's concerns resonate with many other Indian businesses facing similar challenges, underscoring the need for a more nuanced approach to trade policy that balances the goals of self-reliance with the realities of global interdependence.

Bansal’s call is not just about protecting one company; it’s a broader appeal for policymakers to reconsider their strategies and create an environment where Indian businesses can thrive, innovate, and contribute to the nation's economic growth – without being suffocated by unintended consequences of well-intentioned policies. The future of India’s innovation ecosystem may depend on it. To understand the complexities further, exploring related articles like those detailing the "Atmanirbhar Bharat" initiative ([ https://www.businesstoday.in/magazine/policy/atmanirbhar-bharat-a-work-in-progress-314795.html ]) and the challenges faced by Indian startups ([ https://www.businesstoday.in/latest/economy/story/indian-startups-face-funding-crunch-as-investors-turn-cautious-468204-2024-07-19 ]) provides a more comprehensive perspective on the issues at hand.

DIY Woodworking

Announcing The World''s Largest Collection of 16,000 Woodworking Plans

N※N

DIY Woodworking

DIY Woodworking

DIY Woodworking

DIY Woodworking

The Existential Threat How Tariffsanda Science Pushare Challenging Curefits Visionfor Indias Future

DIY Woodworking